妓院一钑片免看黄大片,亚洲av无码成人精品国产,亚洲AV综合色区无码专区桃色,免费A级毛片在线播放不收费

Sequenta  
LymphoSIGHT（淋巴細(xì)胞免疫球蛋白和T細(xì)胞受體測(cè)序）平臺(tái)由Sequenta設(shè)計(jì)，是對(duì)免疫細(xì)胞計(jì)數(shù)的一個(gè)平臺(tái)。用于ALL、慢性淋巴細(xì)胞白血病（CLL）和套細(xì)胞淋巴瘤。
LymphoSIGHT是一個(gè)新型的流式細(xì)胞儀，但靈敏度和特異性提高。與流式細(xì)胞儀不同的是，LymphoSIGHT可以測(cè)定免疫細(xì)胞的DNA含量，DNA含量具有很強(qiáng)的適應(yīng)性，使細(xì)胞根據(jù)需求產(chǎn)生抗體。“這是遺傳多樣性的引擎，有萬(wàn)億種不同組合。這些免疫細(xì)胞會(huì)產(chǎn)生獨(dú)特的DNA標(biāo)簽，因此可以確定樣本中免疫細(xì)胞的特點(diǎn)，” Sequenta執(zhí)行總裁Tom Willis博士說(shuō)。

Sequenta is a venture-backed company dedicated to improving patient care in diseases mediated by immune cells through measurements of lymphocyte diversity. It is commercializing its LymphoSIGHT? platform for clinical use in minimal residual disease while continuing to validate the use of its technology in a diverse set of diseases.